Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know
Sensus Healthcare, Inc. (SRTS) reachead $6.44 at the closing of the latest trading day, reflecting a +1.58% change compared to its last close.
Sensus Healthcare (SRTS) is on the Move, Here's Why the Trend Could be Sustainable
Sensus Healthcare (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Sensus Healthcare, Inc. (SRTS) Ascends While Market Falls: Some Facts to Note
The latest trading day saw Sensus Healthcare, Inc. (SRTS) settling at $5.90, representing a +1.72% change from its previous close.
All You Need to Know About Sensus Healthcare (SRTS) Rating Upgrade to Strong Buy
Sensus Healthcare (SRTS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know
Sensus Healthcare, Inc. (SRTS) closed at $5.80 in the latest trading session, marking a -1.86% move from the prior day.
Sensus Healthcare, Inc. (SRTS) is a Great Momentum Stock: Should You Buy?
Does Sensus Healthcare, Inc. (SRTS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Sensus Healthcare (SRTS) Stock Outpacing Its Medical Peers This Year?
Here is how Sensus Healthcare, Inc. (SRTS) and Assembly Biosciences (ASMB) have performed compared to their sector so far this year.
Recent Price Trend in Sensus Healthcare (SRTS) is Your Friend, Here's Why
Sensus Healthcare (SRTS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Wall Street Analysts Think Sensus Healthcare (SRTS) Could Surge 65.68%: Read This Before Placing a Bet
The consensus price target hints at a 65.7% upside potential for Sensus Healthcare (SRTS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Think Sensus Healthcare (SRTS) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Sensus Healthcare: Recurring Revenue Initiatives Are Exciting
Sensus Healthcare offers equipment for skin problems, with strong demand but vulnerable to economic instability. The company is recovering in 2024, with initiatives for recurring revenue to improve income stability through software and maintenance services. It has begun its expansion to Asia, which in the future could mitigate the risk of customer concentration.
Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year?
Here is how Sensus Healthcare, Inc. (SRTS) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.
